Summit Trail Advisors »

Caris Life Sciences shares owned by Summit Trail Advisors

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Summit Trail Advisors from 13F filings

Historical chart of Summit Trail Advisors investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Summit Trail Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Summit Trail Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $251k 9.3k 26.98

More positions owned by Summit Trail Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Floatng Rat Trea (USFR)
Broadcom (AVGO)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amphenol Corp Cl A (APH)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr 3yrtb Etf (ISHG)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)

View all positions for Summit Trail Advisors

Top funds holding Caris Life Sciences

J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
PointState Capital
Millennium Management
Neuberger Berman Group
OrbiMed Advisors
BlackRock
UBS Group
Point72 Asset Management
Ameriprise Financial
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences